Physician profile
Michael Richard Otten
NPI 1538784814
$4,831.06
in general payments reported to CMS, 2019-2025
8 companies · $2,662 in 2025
The $2,662 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,352 · 2022: $193 · 2023: $331 · 2024: $293 · 2025: $2,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,724 · Food and Beverage: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,723.64 |
| Food and Beverage | $1,562.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,892.68 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Peerless Surgical INC. | $1,224.49 | 2021-2025 | |
| Trimed, INC. | $704.89 | 2025 | |
| Kerecis Limited | $435.63 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $192.79 | 2022 | |
| Integra Lifesciences Corporation | $151.90 | 2021 | |
| Si-Bone, INC. | $141.95 | 2023 | |
| Providence Medical Technology, INC. | $86.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Otten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.